Have any thoughts about
Seagen Inc?
Write Note

Seagen Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Seagen Inc
Revenue Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
S
Seagen Inc
F:SGT
Revenue
$2.3B
CAGR 3-Years
7%
CAGR 5-Years
30%
CAGR 10-Years
24%
Abbvie Inc
NYSE:ABBV
Revenue
$55B
CAGR 3-Years
1%
CAGR 5-Years
11%
CAGR 10-Years
11%
Gilead Sciences Inc
NASDAQ:GILD
Revenue
$27.8B
CAGR 3-Years
1%
CAGR 5-Years
4%
CAGR 10-Years
5%
Amgen Inc
NASDAQ:AMGN
Revenue
$30.9B
CAGR 3-Years
7%
CAGR 5-Years
6%
CAGR 10-Years
5%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Revenue
$10.3B
CAGR 3-Years
16%
CAGR 5-Years
25%
CAGR 10-Years
29%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Revenue
$13.5B
CAGR 3-Years
3%
CAGR 5-Years
16%
CAGR 10-Years
18%

Seagen Inc
Revenue Breakdown

Breakdown by Geography
Seagen Inc

Not Available

Breakdown by Segments
Seagen Inc

Total Revenue: 2B USD
100%
Net Product Sales: 1.7B USD
87%
Royalty Revenues: 164.6m USD
8.4%
Collaboration And License Agreement Revenues: 91.3m USD
4.7%

See Also

What is Seagen Inc's Revenue?
Revenue
2.3B USD

Based on the financial report for Sep 30, 2023, Seagen Inc's Revenue amounts to 2.3B USD.

What is Seagen Inc's Revenue growth rate?
Revenue CAGR 10Y
24%

Over the last year, the Revenue growth was 23%. The average annual Revenue growth rates for Seagen Inc have been 7% over the past three years , 30% over the past five years , and 24% over the past ten years .

Back to Top